Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.51M$1.51Mderived+57.5% vs Q4 2014 Net Income-$1.20M-$1.20MderivedN/M vs Q4 2014 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,419,726N/M Operating Cash Flowderived-$1,317,612N/M Free Cash Flowderived-$1,322,474N/M Margins · derivedOperating margin-93.9%+185.2 pt vs Q4 2014
Net margin-79.3%+120.2 pt vs Q4 2014
ended Dec 31, 2015 · filed Mar 25, 2016 · 85 d after period end